Although previous studies explored the effects of Bifidobacterium or ILA, verifying their association with anti-inflammation 15, 35, our present study elucidates, for the first time, that the differentiation of macrophages during colitis-associated tumorigenesis can be regulated by Bifidobacterium and its associated metabolites. The gene discussed is TNFRSF9; the disease is colitis.